Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
64 /100
HIGH RISK
Score updated Aug 28, 2026

NVNO — enVVeno Medical Corporation Dilution Risk Tracker

Track NVNO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NVNO — Get alerts when the score changes →

As of August 28, 2026, enVVeno Medical Corporation (NVNO) has a DilutionWatch DilutionScore of 64/100, rated HIGH dilution risk. enVVeno Medical Corporation has a market capitalization of $7.56M, 682.7K shares outstanding, 1 institutional holders tracked. Stored dilution-related fields include 861.00M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
40
📊 Float Risk
45
⚠️ Warrant Exposure
90
🔄 Convertible Debt
85

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 50%
📜 Warrant Exercise model 60%
• Massive warrant overhang: 126113% of shares outstanding
• Warrant risk score very high (90/100)
🔁 Convertible Conversion model 60%
• Major convertible overhang: 34% potential dilution
• Convertible risk score very high (85/100)
📉 Score Deterioration model 10%
• Score in HIGH risk zone (64/100)
🔔 Track NVNO — Get forecast alerts →

Market Data

Market Cap$7.56M
Shares Outstanding682.7K
Float486.1K
Cash$21.49M
Debt$603.0K
Short InterestN/A

Institutional Holdings

QoQ: ↓ 99.9% shares (2026Q1 vs prior)
1 institutional holders · 6.6K shares
#1 MORGAN STANLEY 6.6K shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest18.3K
Days to Cover1.0
% of Float3.8%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2018-12-31
4 INSIDER TRANSACTION 2026-03-13
Full SEC filing analysis available with free account

Recent News

No recent news

Factual NVNO Dilution Snapshot

enVVeno Medical Corporation (NVNO) has a DilutionScore of 64/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track NVNO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NVNO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for NVNO
NVNO FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.